Literature DB >> 22447230

Haptoglobin genotype and its role in diabetic cardiovascular disease.

Tina Costacou1, Andrew P Levy.   

Abstract

Over the past decade, several longitudinal epidemiological studies have brought attention to the haptoglobin genotype and its importance in determining diabetic vascular disease risk. This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22447230      PMCID： PMC3595557          DOI： 10.1007/s12265-012-9361-z

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


  105 in total

1.  Tocopherol-associated protein is a ligand-dependent transcriptional activator.

Authors:  J Yamauchi; T Iwamoto; S Kida; S Masushige; K Yamada; T Esashi
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

2.  Structure-function analysis of the antioxidant properties of haptoglobin.

Authors:  M Melamed-Frank; O Lache; B I Enav; T Szafranek; N S Levy; R M Ricklis; A P Levy
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

3.  Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

Authors:  G de Gaetano
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 4.  Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality.

Authors:  T Y Wong; R Klein; B E Klein; J M Tielsch; L Hubbard; F J Nieto
Journal:  Surv Ophthalmol       Date:  2001 Jul-Aug       Impact factor: 6.048

5.  Glucose enhancement of LDL oxidation is strictly metal ion dependent.

Authors:  H O Mowri; B Frei; J F Keaney
Journal:  Free Radic Biol Med       Date:  2000-11-01       Impact factor: 7.376

6.  Familial aggregation of coronary artery calcium in families with type 2 diabetes.

Authors:  L E Wagenknecht; D W Bowden; J J Carr; C D Langefeld; B I Freedman; S S Rich
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

7.  Heritability of carotid artery intima-medial thickness in type 2 diabetes.

Authors:  Leslie A Lange; Donald W Bowden; Carl D Langefeld; Lynne E Wagenknecht; J Jeffrey Carr; Stephen S Rich; Ward A Riley; Barry I Freedman
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

Review 8.  Biological and clinical significance of haptoglobin polymorphism in humans.

Authors:  M R Langlois; J R Delanghe
Journal:  Clin Chem       Date:  1996-10       Impact factor: 8.327

9.  Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial.

Authors:  J M Rapola; J Virtamo; J K Haukka; O P Heinonen; D Albanes; P R Taylor; J K Huttunen
Journal:  JAMA       Date:  1996-03-06       Impact factor: 56.272

10.  Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung.

Authors:  F Yang; W E Friedrichs; A L Navarijo-Ashbaugh; L A deGraffenried; B H Bowman; J J Coalson
Journal:  Lab Invest       Date:  1995-09       Impact factor: 5.662
View more
  22 in total

1.  The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.

Authors:  Tina Costacou; Trevor J Orchard
Journal:  J Diabetes Complications       Date:  2015-11-14       Impact factor: 2.852

Review 2.  Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control.

Authors:  Rachel G Miller; Tina Costacou
Journal:  Curr Cardiol Rep       Date:  2022-08-10       Impact factor: 3.955

3.  Evaluation of serum haptoglobin levels and Hp1-Hp2 polymorphism in the haptoglobin gene in patients with atrial fibrillation.

Authors:  Luana Bernardes Xavier Costa; Gabriela Lopes Martins; Rita Carolina Figueiredo Duarte; Pâmella Lemos Rocha; Estêvão Lanna Figueiredo; Francisco Rezende Silveira; Maria das Graças Carvalho; Helton José Reis; Karina Braga Gomes; Cláudia Natália Ferreira
Journal:  Mol Biol Rep       Date:  2022-05-16       Impact factor: 2.742

4.  Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome.

Authors:  Laura M L Carvalho; Cláudia N Ferreira; Daisy K D de Oliveira; Kathryna F Rodrigues; Rita C F Duarte; Márcia F A Teixeira; Luana B Xavier; Ana Lúcia Candido; Fernando M Reis; Ieda F O Silva; Fernanda M F Campos; Karina B Gomes
Journal:  J Assist Reprod Genet       Date:  2017-09-13       Impact factor: 3.412

5.  Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.

Authors:  Tina Costacou; Aaron M Secrest; Robert E Ferrell; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2014-07-03       Impact factor: 3.291

6.  Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.

Authors:  T Costacou; R W Evans; T J Orchard
Journal:  Diabet Med       Date:  2016-04-20       Impact factor: 4.359

7.  Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.

Authors:  Niyati U Mehta; Victor Grijalva; Susan Hama; Alan Wagner; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-14       Impact factor: 8.311

8.  Diabetic complications: current challenges and opportunities.

Authors:  Helen D Nickerson; Sanjoy Dutta
Journal:  J Cardiovasc Transl Res       Date:  2012-06-30       Impact factor: 4.132

Review 9.  Atherogenesis and iron: from epidemiology to cellular level.

Authors:  Francesca Vinchi; Martina U Muckenthaler; Milene C Da Silva; György Balla; József Balla; Viktória Jeney
Journal:  Front Pharmacol       Date:  2014-05-05       Impact factor: 5.810

Review 10.  Natural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobin.

Authors:  Viktória Jeney; John W Eaton; György Balla; József Balla
Journal:  Oxid Med Cell Longev       Date:  2013-05-16       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.